Evan Jones, has over two decades of operating and investment experience in the life sciences industry where he has founded or helped start numerous life sciences companies. As co-founder and CEO of Digene Corporation (acquired by QIAGEN in 2007), a publicly traded biotechnology company focused on women’s health and molecular diagnostic testing, Evan was deeply involved in commercializing and bringing public awareness to the first molecular test for human papillomavirus, which made possible early detection of cervical cancer and dramatically reduced mortality for this cancer. Evan served as Chief Executive Officer of Digene Corp from 1990 to 2006. From 1988 to September 1990, he served as President of Neomorphics, Inc.
Mr. Jones is a member of the board of directors of CAS Medical Systems, Inc., a developer of patient vital signs monitoring products and technologies, and Veracyte, Inc., a private venture-backed company developing molecular tests to improve the diagnostic accuracy of cytology samples. Mr. Jones is also a member of the board of directors of the Children’s National Medical Center and the Children’s Research Institute in Washington, D.C. He is chairman of the Campaign for Public Health Foundation, an independent, not-for-profit organization dedicated to increasing funding for the Centers for Disease Control and Prevention and is a member of the board of directors and the Executive Committee of Research!America, a not-for-profit public education and advocacy alliance.
Mr. Jones received a B.A. degree from the University of Colorado and an M.B.A. degree from The Wharton School at the University of Pennsylvania.